Cargando…
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss
The use of megestrol acetate in the treatment of weight loss in gastrointestinal cancer patients has been disappointing. The aim of the present study was to compare the combination of megestrol acetate and placebo with megestrol acetate and ibuprofen in the treatment of weight loss in such patients....
Autores principales: | McMillan, D C, Wigmore, S J, Fearon, K C H, O'Gorman, P, Wright, C E, McArdle, C S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362415/ https://www.ncbi.nlm.nih.gov/pubmed/10027319 http://dx.doi.org/10.1038/sj.bjc.6690077 |
Ejemplares similares
-
A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients.
por: McMillan, D. C., et al.
Publicado: (1997) -
Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006) -
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer.
por: Scott, H. R., et al.
Publicado: (1996) -
Megestrol Acetate-Induced Symptomatic Hypogonadism in a Male Patient
por: Munshi, Lubna Bashir, et al.
Publicado: (2018) -
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
por: Ruiz‐García, Vicente, et al.
Publicado: (2018)